Oncogenes y Dianas Efectoras
PANCCUN
![Foto de Oncogenes y Dianas Efectoras](/img/uploaded/cfbefccdba02742414c74e77b99a3a7b.jpg)
![Foto de New York University Langone Medical Center](/img/noimage_org.png)
New York University Langone Medical Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de New York University Langone Medical Center (1)
2021
-
Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027